BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7530798)

  • 1. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors.
    Panetta R; Patel YC
    Life Sci; 1995; 56(5):333-42. PubMed ID: 7530798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
    Horiguchi K; Yamada M; Umezawa R; Satoh T; Hashimoto K; Tosaka M; Yamada S; Mori M
    Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction.
    Murabe H; Shimatsu A; Ihara C; Mizuta H; Nakamura Y; Nagata I; Kikuchi H; Nakao K
    J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
    Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
    J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.
    Taboada GF; Luque RM; Bastos W; Guimarães RF; Marcondes JB; Chimelli LM; Fontes R; Mata PJ; Filho PN; Carvalho DP; Kineman RD; Gadelha MR
    Eur J Endocrinol; 2007 Jan; 156(1):65-74. PubMed ID: 17218727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.
    Greenman Y; Melmed S
    J Clin Endocrinol Metab; 1994 Sep; 79(3):724-9. PubMed ID: 7521350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors.
    Greenman Y; Melmed S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):398-403. PubMed ID: 8106629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.
    Zatelli MC; Piccin D; Tagliati F; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Culler MD; degli Uberti EC
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2797-802. PubMed ID: 12788890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis.
    Day R; Dong W; Panetta R; Kraicer J; Greenwood MT; Patel YC
    Endocrinology; 1995 Nov; 136(11):5232-5. PubMed ID: 7588263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental changes in the expression of somatostatin receptors (1-5) in the brain, hypothalamus, pituitary and spinal cord of the human fetus.
    Goodyer CG; Grigorakis SI; Patel YC; Kumar U
    Neuroscience; 2004; 125(2):441-8. PubMed ID: 15062986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.
    Corbetta S; Ballaré E; Mantovani G; Lania A; Losa M; Di Blasio AM; Spada A
    Eur J Clin Invest; 2001 Mar; 31(3):208-14. PubMed ID: 11264647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor profile in pituitary thyrotroph adenomas.
    Thodou E; Kontogeorgos G
    Clin Neurol Neurosurg; 2020 Aug; 195():105865. PubMed ID: 32416325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.
    Nielsen S; Mellemkjaer S; Rasmussen LM; Ledet T; Olsen N; Bojsen-Møller M; Astrup J; Weeke J; Jørgensen JO
    J Endocrinol Invest; 2001 Jun; 24(6):430-7. PubMed ID: 11434667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.
    Shimon I
    Endocrine; 2003 Apr; 20(3):265-9. PubMed ID: 12721506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
    Tateno T; Kato M; Tani Y; Oyama K; Yamada S; Hirata Y
    Endocr J; 2009; 56(4):579-84. PubMed ID: 19318729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
    Panetta R; Greenwood MT; Warszynska A; Demchyshyn LL; Day R; Niznik HB; Srikant CB; Patel YC
    Mol Pharmacol; 1994 Mar; 45(3):417-27. PubMed ID: 7908405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary and hypothalamic somatostatin receptor subtype messenger ribonucleic acid expression in the food-deprived and diabetic rat.
    Bruno JF; Xu Y; Song J; Berelowitz M
    Endocrinology; 1994 Nov; 135(5):1787-92. PubMed ID: 7956902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
    Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
    Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
    Jaquet P; Saveanu A; Gunz G; Fina F; Zamora AJ; Grino M; Culler MD; Moreau JP; Enjalbert A; Ouafik LH
    J Clin Endocrinol Metab; 2000 Feb; 85(2):781-92. PubMed ID: 10690891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.